A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

The pharmacokinetics (PK) and pharmacodynamics (PD) of metronomic irinotecan have not been studied in cancer patients. The aim of the study is to investigate the PK/PD profile of irinotecan/SN-38 administered by metronomic schedule. Twenty chemotherapy-refractory or chemotherapy-resistant patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Allegrini, G, Falcone, A, Fioravanti, A, Barletta, M T, Orlandi, P, Loupakis, F, Cerri, E, Masi, G, Di Paolo, A, Kerbel, R S, Danesi, R, Del Tacca, M, Bocci, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361703/
https://www.ncbi.nlm.nih.gov/pubmed/18362940
http://dx.doi.org/10.1038/sj.bjc.6604311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361703/
https://www.ncbi.nlm.nih.gov/pubmed/18362940
http://dx.doi.org/10.1038/sj.bjc.6604311

Ejemplares similares